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Abstract
Objective: Spontaneous intracerebral hemorrhage (ICH) is the commonest
form of hemorrhagic stroke and is associated with a poor prognosis. Neurosur-
gical removal of intracerebral hematoma has limited benefit and no pharma-
cotherapies are available. In acute ICH, primary tissue damage is followed by
secondary pathology, where the cellular and neuroinflammatory changes are
poorly understood. Methods: We studied histological changes in postmortem
tissue from a cohort of spontaneous supra-tentorial primary ICH cases
(n = 27) with survival of 1–12 days, compared to a matched control group
(n = 16) examined in corresponding regions. Hematoxylin–eosin and microglial
(Iba1) immunolabelled sections were assessed at 0–2, 3–5, and 7–12 days post-
ICH. Results: Peri-hematoma, the observed ICH-related changes include
edema, tissue neutrophils and macrophages from day 1. Ischemic neurons and
swollen endothelial cells were common at day 1 and universal after day 5, as
were intramural erythrocytes within small vessel walls. Activated microglia were
evident at day 1 post-ICH. There was a significant increase in Iba1 positive area
fraction at 0–2 (threefold), 3–5 (fourfold), and 7–12 days post ICH (ninefold)
relative to controls. Giant microglia were detected peri-hematoma from day 5
and consistently 7–12 days post-ICH. Interpretation: Our data indicate that
neuroinflammatory processes commence from day 1 post-ICH with changing
microglial size and morphology following ICH and up to day 12. From day 5
some microglia exhibit a novel multiply nucleated morphology, which may be
related to changing phagocytic function. Understanding the time course of neu-
roinflammatory changes, post-ICH may reveal novel targets for therapy and
brain restoration.
Introduction
Spontaneous intracerebral hemorrhage (ICH) is a devas-
tating cause of morbidity and mortality. The annual
incidence ranges from 16 to 25 per 100,000 world-
wide1,2 with 40% mortality at 1 month.2 Risk factors
include age (with significant increase in incidence above
the age of 553), male gender, hypertension (HTN), and
African American or Hispanic race.4–6 The main age-re-
lated vessel pathologies considered to underlie sponta-
neous ICH (primary ICH) are small vessel disease
(arteriolosclerosis) and cerebral amyloid angiopathy
(CAA).7–9
In addition, structural pathological processes associated
with secondary ICH include ruptured aneurysm, vascular
malformation, tumors, and hemorrhagic infarcts. Systemic
factors (e.g., hematological malignancies, thrombocytope-
nia, and coagulopathies) are of etiologic importance and
an associated ICH may be considered either primary or
secondary brain hemorrhage.
Large spontaneous ICH causes instantaneous disruption
of surrounding brain, termed mass effect, and is often
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rapidly fatal. ICH with mass effect and rise in intracranial
pressure can be surgically evacuated to reduce the pri-
mary brain injury. Current treatment approaches to spon-
taneous ICH include (1) surgical evacuation of accessible
hematoma, (2) controlling blood pressure, and (3) revers-
ing anticoagulation, where applicable.10–13 Although sur-
gical evacuation has the potential to reduce brain tissue
damage, by relieving local ischemia or removal of noxious
chemicals,14,15 class I evidence from clinical trials does
not demonstrate improved outcomes.10,13,16,17
The cellular mechanisms that underlie pathophysiologi-
cal changes around the hematoma are poorly understood.
Activation of inflammatory cascades and the release of
cytotoxic mediators are implicated.15,18,19 These cause cell
death and functional impairment, and are considered the
hallmark of secondary brain damage.20 Understanding the
inflammatory processes that follow ICH in humans may
offer new therapeutic opportunities.
In healthy adult brain, microglia exhibit ramified mor-
phology.20 In response to brain injury, microglia become
activated and undergo morphological and functional
transformations. Their cell bodies become enlarged, dense,
with thicker processes, inflammatory proteins are upregu-
lated, and the cells become migratory, proliferative, and
phagocytic.19–23 Activated microglia can have either neu-
rotoxic or neuroprotective properties and their overall
effect depends on the type and severity of brain insult.24
Here, we hypothesized that microglial phenotype and
morphology are altered in human spontaneous ICH.
We performed histopathological assessment of tissue
obtained from subjects who died from spontaneous
supra-tentorial ICH. We examined tissue from the margin
of the hematoma in 27 ICH cases, and analogous tissue
samples from 16 control subjects. We report significant
changes in the size and morphology of Iba1-labelled
microglia in human ICH.
Materials and Methods
Human tissue
This is a postmortem study of spontaneous ICH cases
(N = 27, M = 13, F = 14, age range 19–90 years old,
median = 59 years old; Table 1). Standard tissue blocks
(1–2 blocks per case) were taken from tissue at the border
of the hemorrhage and the average results for each case
presented. A group of control subjects (N = 16) deceased
due to non-neuropathological cause (M = 11, F = 5,
range 26–60, median 51 years old) were also examined in
the same anatomical regions.
All ICH cases are of spontaneous supra-tentorial hem-
orrhage (either lobar ICH or deep ICH within the basal
ganglia or thalamus, Fig. 1A and B) with no known
underlying structural abnormalities. Postmortem reports
from the brain tissue banks were reviewed for location,
dimension of the hematoma, intraventricular extension,
brainstem hemorrhage, and comorbidities that include
HTN, inflammatory diseases, Alzheimer’s disease pathol-
ogy (Table 1). ICH volume was estimated from the post-
mortem report when available. The ABC/2 technique is a
known and reliable bedside method for measuring ICH
volume from the computerized tomography (CT) head
which has been widely validated.25,26 In the ABC/2
method, A is the greatest hemorrhage diameter by CT, B
is the diameter perpendicular to A, C is the approximate
number of CT slices with hemorrhage multiplied by the
slice thickness.
Ethics approval
Ethical approval was provided by BRAIN UK (Research
Ethics Committee South Central Hampshire B, reference
14/SC/0098) for the cases sourced from St George’s
University Hospital NHS Foundation Trust, North Bristol
NHS Trust, and University Hospitals Plymouth NHS
Trust. The cases provided by the Oxford Brain Bank and
University of California, Irvine were covered by the ethics
reference 12/EM/0028 from Health Authority Service,
NRES Committee East Midlands-Derby.
Immunohistochemistry
Sections of formalin-fixed paraffin embedded tissue were
processed for hematoxylin–eosin (H&E) and immunohis-
tochemistry as described previously.27,28 Briefly, sections
(6 µm) were de-waxed and processed for standard
immunohistochemical labelling. Endogenous peroxidase
activity was blocked by exposure to H2O2 (3% v/v, aque-
ous solution) for 10 min. After high-pressure heat-in-
duced antigen retrieval (30 sec, 125°C, in pH7.8 Tris-
citrate buffer), nonspecific binding was blocked with PBS
supplemented with Triton-X100 (0.1%) and BSA (3%)
(PBT-BSA) for 60 min at room temperature and sections
were incubated with the primary microglial antibody Iba1
(1:800 in PBT-BSA, MP-290-CR01, A.Menarini Diagnos-
tics Ltd, Wokingham, UK) at 4°C overnight. Antibody
labelling was visualized using a peroxidase-conjugated sec-
ondary reagent (Envision kit, K500711, Agilent Tech-
nologies LDA, Oxford, UK) and diaminobenzidine
chromagen, then counterstained for nuclear chromatin
with Mayer’s hematoxylin. As a negative control, neigh-
boring sections were treated with irrelevant primary anti-
body (rabbit anti-sheep IgG; BD-Pharmingen).
Immunolabelling for the T-cell marker CD3 was per-
formed on a VENTANA BenchMark Immunohistochem-
istry automated staining machine in St George’s Hospital
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Cellular Pathology diagnostic service. The primary anti-
body is rabbit monoclonal IgG (clone 2GV6, Ventana-
Roche, Tucson, AZ) raised against a synthetic peptide
from the C-terminus of CD3 epsilon chain, found in T
cells and NK cells.
For immunofluorescence, paraffin sections (6 lm
thickness) were processed for labelling as in our previous
work.29,30 Heat-induced antigen retrieval was performed
using a Menarini-Biocare decloaker, (120°C, 30 sec, in
citrate buffer pH6). Nonspecific binding was blocked by
incubation with 6% w/v BSA (Jackson Immunochemicals,
Cambridgeshire, UK) in PBS-T for 1 h at room tempera-
ture. Sections were incubated overnight in a humidified
chamber at 4°C with the same primary antibody Iba1
(1:200) diluted in 6% w/v BSA in PBS-T. Sections were
incubated with appropriate secondary antibodies conju-
gated to Alexa546 or Alexa647, diluted 1:300 in 6% BSA
in PBS-T at room temperature for 1 h. After nuclear
labelling with DAPI (20 min, 0.3 µmol/L in PBS-T), sec-
tions were mounted and photographed with a Nikon A1R
confocal microscope. Red fluorescence was viewed with
543 nm excitation and 545–575 nm emission bandwidth.
Far red fluorescence was viewed with 640 nm excitation
and 663–738 nm emission bandwidth. DAPI was viewed
with 405 nm excitation and 425–475 nm emission band-
width. Neighboring sections were processed identically in
parallel, but with omission of primary antibodies.
Histopathology assessment
Microscopic examination was performed independently
by two neuropathologists (L. R. B. and M. M. E.) on the
H&E stained sections from all tissue blocks to identify the
pattern of hematoma and peri-hematoma changes. They
were blind to clinical and autopsy data. Quantification, as
absent or present, included the following features, neu-
trophils, macrophages, edema, red neurons, reactive astro-
cytes, small vessel intramural blood cells, and thickened
small vessel endothelial cells (Fig. 2). Inter-rater differ-
ences were reviewed and consensus achieved by discus-
sion. Microscopic examination of T-cells stained sections
was performed blindly by neuropathologist (L. R. B.).
Table 1. Characteristics of the cases.
Number Age/sex
ICH location (lobar vs. deep [basal
ganglia/thalamus])
Time from hemorrhage to
death (days)
Known relevant past
medical history
Estimated ICH
volume (mL)
1 86/M Lobar NA AD NA
2 90/F Deep NA AD, HTN NA
3 82/M Lobar NA AD, IHD NA
4 82/F Deep NA AD NA
5 90/M Lobar NA None NA
6 76/M Lobar NA AD, CAA NA
7 90/M Lobar NA AD NA
8 90/M Lobar NA AD NA
9 75/F Deep 2 None NA
10 40/F Deep 2 Leukaemia NA
11 52/M Deep 4 None NA
12 79/F Lobar 12 None 42
13 56/F Deep 12 None NA
14 52/F Deep 1 None NA
15 58/F Deep 1 None 27
16 59/M Lobar 7 HTN NA
17 78/M Lobar 10 None NA
18 30/M Lobar 3 HTN 30
19 55/F Deep 5 HTN 67.5
20 19/F Lobar 8 pneumonia 188
21 53/F Lobar 3 None 36
22 53/F Lobar 1 None 67
23 27/F Lobar Within 1 Drug abuser, seizures 67
24 52/F Deep 3 COPD, IHD 35
25 65/M Deep 3 Alcoholism, Leukaemia 80
26 49/M Lobar 3 Alcoholism, HTN 21
27 65/M Deep Within 1 HTN, DMII 316
ICH, intracerebral hemorrhage; AD, Alzheimer’s disease; HTN, hypertension; CAA, cerebral amyloid angiopathy; COPD, chronic obstructive pul-
monary disease; IHD, ischemic heart disease; DMII, diabetes mellitus type two; NA, not available.
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Microglial quantification
Iba1-immunolabelled slides were digitized at 209 magni-
fication using a slide scanner (Hamamatsu WEB, Welwyn
Garden City, Hertfordshire, UK). From the scanned slide,
10 images from the peri-hematoma area were digitally
acquired using NDP View software (Hamamatsu WEB)
and analysed with Image J (Version 1.51j8, Wayne Ras-
band, NIH, Wisconsin). MaxEntropy macro filter was
exclusively applied to threshold the images. Labelled-area
Figure 1. CT head and postmortem brain with ICH. (A) Axial CT head image shows right spontaneous deep thalamic hemorrhage. (B) Axial CT
head image demonstrates spontaneous left temporo-parietal (lobar) ICH. (C) Coronal section of a postmortem human brain with ICH. White
arrow shows the hemorrhage and arrow heads show sampled areas. (D) H&E of an ICH human brain section. Arrow locates the hemorrhage.
Arrow head shows the perilesional area that has been quantified and analysed. CT, computerized tomography; ICH, intracerebral hemorrhage;
H&E, hematoxylin–eosin.
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fraction (%AF) is reported as 1009 (number of pixels
positive for Iba1)/total number of pixels.
Microglial morphology assessment
In ICH-scanned sections, areas of maximal changes,
defined as high cell density areas, were identified adjacent
to the hematoma region. The morphology of Iba1-labelled
cells was assessed using the zoom in function of
NDP.view2 Viewing software (Hamamatsu WEB) at 409
magnification. For comparison, similar areas in the same
section were examined distant from the hematoma, and
in sections from control cases.
Briefly we describe physiological microglia that become
activated, then progress to reactive passing through a
transitional stage, with the reactive cells becoming amoe-
boid/phagocytic before some start fusing together in a
stage we named “fusion stage” to form bi/tri-nucleated
giant cell (Fig. 3). Each microglial morphology was
defined as follows:
Ramified/ physiological microglia possess a small (5–
10 µm) oval cell body. The nucleus fills most of the soma
leaving a very small volume of cytoplasm. Radiating from
the soma are numerous processes of small diameter.
These processes typically extend several times the diame-
ter of the cell body in length, often branch, and usually
exhibit a rough or spiny surface (Fig. 3A and B).23,31–33
Activated microglia are swollen ramified cells and are
characterized by a larger and denser cell body with
shorter, and stouter processes (Fig. 3C and D).31–33
Transitional microglia are activated cells that appear to
bead off their processes. They have dense cell body with
an irregular shape (Fig. 3E and F). Some of these descrip-
tions may be in part resembling dysmorphic microglia.
However, dysmorphic microglia has been suggested to be
due to microglial dysfunction as a result of aging23 which
is not the case in our cohort.
Reactive microglia are typically small, spherical cells, but
can also exhibit rod-shaped and pleomorphic or amoe-
boid-like morphologies. They lack ramified-type processes
(Fig. 3G and H).31,32
Amoeboid microglia are spherical in shape, lack pro-
cesses, and contain numerous phagocytic vacuoles
(Fig. 3G and H). They are also defined as macrophage-
like morphology and are undistinguishable from recruited
macrophages.
Early on, reactive or amoeboid microglia adhere or fuse
together to form giant nucleates cells with no space between
the cells. Some cells presented visible cell walls that were
partly degraded in order to form giant cells. Nuclei are
usually located in periphery of the cytoplasm (Fig. 3I). In
this paper, for the first time, we are reporting the forma-
tion of a giant/large cell in the context of human ICH
with cross-sectional area ranges between 423–767 µm2.
Figure 2. Acute cellular changes following spontaneous ICH in human. (A) Presence of neutrophils (arrows), (a) and at higher magnification. (B)
Recruited macrophages, (b) and at higher magnification. (C) Red Neurons (black arrows) and vacuoles demonstrating edema (yellow arrows), (c)
and at higher magnification. (D) Reactive astrocytes (white arrows), (d) and at higher magnification. (E) A small vessel with erythrocytes dissecting
its wall (arrow), (e) and at higher magnification. (F) Thickened small vessel endothelial cells (arrow), (f) and at higher magnification. Scale bar
50 µm. ICH, intracerebral hemorrhage.
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The cross-sectional area of microglial cell body was
measured with the processes excluded in the case of phys-
iological and activated microglia. This was achieved by
drawing the margins of the cell body of Iba1-labelled cells
using the freehand region function of NDP.view2 Viewing
software (Hamamatsu WEB) at 409 magnification
(Fig. 3J). Ten cells per type per case were assessed.
Statistical analysis
Descriptive analysis was performed to assess the normality
of the data. For some of the analyses, the ICH cases were
split according the time from hemorrhage to death
including 0–2 days (N = 7); 3–5 days (N = 7) and 5–
12 days (N = 5).
The data were parametric and the Student’s t-test used
to assess Iba1 AF (%) between ICH and control cohorts
and within the ICH cases divided according age at death
or the hemorrhage location. One-Way ANOVA with
Dunnett’s posthoc test was performed to analyse the tem-
poral course of microglia and size of the microglial cell
body between the different microglial morphologies iden-
tified. Chi-squared test (v2) analyzed whether HTN influ-
enced the location of ICH. GraphPad Prism software was
used to perform the statistical analysis, with P-value con-
sidered significant when <0.05.
Results
Gross pathology of spontaneous ICH cases
Among the 27 ICH cases examined, deep ICH was
recorded in 12 cases and lobar hemorrhage in 15 cases
and (Table 1). Six were known hypertensives (three deep
ICH and three lobar ICH; P = 0.76, v2). Seven lobar ICH
patients were diagnosed neuropathologically with Alzhei-
mer’s disease. The hematoma dimensions were available
for 12 cases (estimated volume 21–316 mL). Data about
intraventricular extension of the ICH were available for
19 subjects of whom 14 (74%) had intraventricular exten-
sion of the ICH. Accurate data about time from ictus to
death was available for 19 ICH cases (range 24 h–
12 days). No AVM or other underlying structural abnor-
malities were known or identified on postmortem exami-
nation. The cause of death of all our cases was reported
as spontaneous “acute ICH.”
Histopathological changes in acute
spontaneous ICH
On examination of H&E sections from ICH cases, neu-
trophils were present in the peri-hematoma area as early
as 1 day following the hemorrhage. Neutrophil infiltration
was evident within 2 days of the ICH in most cases
(63%), and in all cases by 5 days, up to 12 days, irrespec-
tive of whether the bleed was lobar or deep. Tissue
macrophages, ischemic eosinophilic neurons (“red neu-
rons”), swollen endothelia and reactive astrocytes were
commonly observed at 1–2 days post-ICH, and were uni-
versally present at 5–12 days (Fig. 2). Red blood cells
within the wall of small vessels (intramural erythrocytes)
were observed in 75% of subjects within days 0–2 and in
all cases 5–12 days following the ICH (Fig. 2E and e).
Edema was observed in the peri-hematoma region from
1 day post-ICH and subsequently in all ICH cases. Five
out of eight ICH cases with Alzheimer’s disease had thick-
ening of small vessel endothelial cells regardless of the
time of death after ICH. All of the known hypertensive
subjects had thickening of small vessel endothelial cells,
regardless of time of death post-ICH. None of these
histopathological features was observed in the 16 control
cases.
Iba1 microglia following acute spontaneous
ICH
Neighboring sections labelled with a microglial marker
(Iba1) showed microglial cells adjacent to the hematoma
(Figs. 4, 5). Semi-quantitative assessment of the Iba1-pos-
itive area fraction (%AF) confirmed fourfold greater
extent of microglial labelling in ICH compared to con-
trols (10.2  1.3 %, 2.4  0.2%, respectively, P < 0.0001,
Fig. 4A). There was significant change in AF% with time
post-ICH (P < 0.05, Fig. 4B). At days 3–5, Iba1 AF (%)
Figure 3. Morphologies of Iba1-microglia in human brain tissue from control and spontaneous ICH cases. (A) Ramified microglia in a control
subject defined by a small cell body which is <10 µm and multiple processes a few times longer than the cell body (arrow). (B) Higher
magnification of a ramified cell, scale bar = 21 µm. (C) Activated microglia following brain hemorrhage, cell bodies are swollen, denser and larger
than ramified microglia, processes are shorter and stouter, (arrows). (D) Higher magnification of activated microglia, scale bar = 50 µm. (E)
Transitional microglia, processes fragments from dense cell body (arrows). (F) Higher magnification, scale bar = 50 µm. (G) Reactive microglia are
typically small, spherical cells, but can also exhibit rod-shaped and pleomorphic or amoeboid-like morphologies; all lack ramified-type processes
(red arrows), amoeboid/phagocytic microglia are larger than reactive cells with fainter cytoplasm and dense nucleus located at the periphery of
the cell body. They display various round and irregular shapes (green arrows). (H) Higher magnification of reactive microglia (red arrows) and
amoeboid microglia (green arrows), scale bar = 50 µm. (I) Fusion stage of amoeboid microglia (green arrows) to form giant/large microglial cells
where we noted bi/tri-nucleate cells or fragmented nucleus or absence of nucleus, (red arrows). (J) Magnified picture of a bi-nucleate giant
microglia with an outlined boundaries to measure the cell surface area. Scale bar = 50 µm. ICH, intracerebral hemorrhage.
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increased significantly in comparison with controls
(P < 0.01) and was nine times higher in subjects dying
between 5 and 12 days post-ICH (P < 0.001; ICH:
20.92  0.1.7% vs. controls: 2.4  0.2%).
To test for age dependence, we dichotomized the
cohort to those aged <60 years and those aged 60 or
more. There was no significant difference in Iba1 AF (%)
between these age groups (Fig. 4C). We observed a trend
toward greater Iba1 AF (%) in lobar ICH (12.3  2.0%)
compared with deep ICH (7.5  1.3%, P = 0.06;
Fig. 4D).
Temporal course of morphological changes
of Iba1-microglia
In Iba1-labelled sections transitional, reactive, and amoe-
boid microglia were observed within 2 mm of the hema-
toma from 24 h post-ICH (Fig. 5). Activated microglia
were observed in the neighboring 5 mm and white matter
tracts (examples in Fig. 5a1). Ramified microglia were
also seen in the same cases, adjacent to the hematoma
and in locations distant from the hematoma (Fig. 5a1,
a2).
At 3–5 days post-ICH, reactive and amoeboid micro-
glial cells remained abundant 2–3 mm of the hemorrhage,
as well as clusters of Iba1 cells (Fig. 5B and b). In addi-
tion, some large bi- or tri-nucleated Iba1-positive cells
were seen. These were much larger than the other micro-
glial cells, with an overall amoeboid morphology, that we
have termed giant microglia (examples in Fig. 6). Rami-
fied microglia were less evident adjacent to the hema-
toma, while activated and transitional microglia were seen
in the rest of the tissue section.
From day 5 post-ICH, reactive, amoeboid microglia
were common within 2–3 mm of the hemorrhage
(Fig. 5C and D). Clusters of amoeboid microglia were
observed around medium-sized blood vessels (Fig. 5C
and c). Bi-/tri-nucleate and occasional multinucleate giant
microglia were also commonly seen adjacent to the hema-
toma. Within the rest of the tissue section, reactive and
transitional microglia were observed, while ramified
microglia were sparse or absent.
The presence and morphology of bi- and tri-nucleated
giant microglia were confirmed by orthogonal and 3D
confocal micrographs of Iba1-labelled sections using
immunofluorescence (Fig. 6).
CD3-labelled T cells following ICH
CD3-immunopositive T cells were seen in all cases (con-
trol and hemorrhage) in blood inside vessels. They were
also seen in the hemorrhage cases within the blood clots.
T cells were also seen in all cases (control and hemorrhage)
around blood vessels in the Virchow-Robin space (Fig. S1).
The significance of this is uncertain but the numbers of T
cells were few and not noticeably different between control
and hemorrhage cases. It could be that they represent a
response to old nonspecific minor insult (they were often
associated with a few hemosiderin-laden macrophages).
None of the controls showed parenchymal T cells.
Assessment of the brain parenchyma in the hemorrhage
cases was done carefully to exclude T cells which were
just part of the blood clot. In 11 out of 12 acute hemor-
rhage (1–3 days) cases, there were no parenchymal T
cells; the remaining case (at 3 days) showed appreciable T
cells (Fig. S2). In later hemorrhage cases, scanty parenchy-
mal T cells were present in one case each at 7 and 8 days.
One case at 12 days (without obvious organisation – vas-
cularisation – of the clot) showed only a few parenchymal
T cells. Another case at 12 days (with clear organisation
of the clot) showed moderate T cells in the organising tis-
sue and the brain parenchyma (Fig. S3).
The cross-sectional area of microglia cell
bodies
We measured the cross-sectional area of microglia cell
bodies from the different morphologies identified. The
surface area of activated microglia was significantly larger
than ramified microglia (189.9  28.3 µm2,
11.23  1.8 µm2 respectively P < 0.001, Fig. 5E). The
cross-sectional area of reactive microglial cells was not
significantly different from ramified microglia (Fig. 5E).
Amoeboid cells had significantly larger cell bodies than
Figure 4. Iba1 microglia in control and ICH subjects. (A) Iba1 %AF (%) microglia increased significantly in 27 ICH subjects when compared to 18
controls (P < 0.0001). (B) Iba1 % increased significantly in subjects who died 1 day after ICH and 3–5 days after ICH. The greatest change was
observed in subjects dying 5–12 days post-ICH. (C) Iba1 microglial expression did not change when comparing those above 60 years old (n = 14)
with those below 60 years old (n = 13; P = 0.54). (D) A trends toward increase was detected for Iba1 load in lobar ICH (n = 15, 12.3%) when
compared to deep ICH (n = 12, 7.5%; P = 0.06). *P < 0.05, **P < 0.01, ***P < 0.00. (E) Iba1 microglia in control and ICH subjects (peri-
hemorrhage and distant from hemorrhage). Iba1 %AF (%) microglia increased significantly in 27 ICH subjects when compared to 18 controls
(P < 0.0001). There was no significant difference in Iba1 load when comparing distant from hemorrhage (a lobe from hemorrhage or equivalent
contralateral anatomical area) quantification to control (n = 13, 4.9% vs. 2.4% in controls, P = 0.52). There was a significant increase in Iba1 %
AF in ICH when compared to distant from hemorrhage (10.16% vs. 4.9% P = 0.007). One-way ANOVA with Bonferroni’s posthoc test.
*P < 0.05, **P < 0.01, ***P < 0.001. ICH, intracerebral hemorrhage.
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ramified cells (P = 0.004). However, the largest among all
were the giant/large microglial cells with a mean of
584  33.8 µm2 (minimum 423 µm2 and maximum
767 µm2 P = 0.0001). These measurements were repeated
with 30 day interval and showed good intra-rater agree-
ment (j = 0.88).
Discussion
We studied the histological changes in spontaneous ICH
and their temporal course in 27 spontaneous ICH cases.
Some of the included subjects who presented with ICH
may have had undiagnosed HTN, as the proportion of
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known hypertensive subjects in our study is lower than
those reported in the literature.34,35 Seven ICH cases had
neuropathological diagnosis of AD and in these individu-
als CAA may be the cause of ICH.36 Intraventricular
extension of ICH, a factor associated with poor progno-
sis,37 was reported in 74% of our cases, consistent with
the time from hemorrhage to death of our cohort.
Edema in the peri-hematoma region was detected
from day 1 post-ICH and was a consistent feature in all
ICH cases. Our observation is consistent with peri-he-
matoma edema reported from head scans of ICH
patients within 1 day of the hemorrhage and in associa-
tion with poorer outcome.19,38 Red neurons indicative of
ischemic neuronal damage were present within the peri-
hematoma area in most (88%) of the subjects within
3 days of the ICH and up to 12 days post-ICH. Neu-
trophils are widely considered to be the earliest leukocyte
subtype to infiltrate into the hemorrhagic brain. As neu-
trophils are known to produce reactive oxygen species
which cause neurotoxicity and contribute to brain dam-
age in animals,39 their early presence and leakage of their
contents is associated with brain tissue damage.20 The
temporal course of neutrophil infiltration in human ICH
is relatively unexplored.19 In our human cohort, we
observed neutrophil infiltration within 2 days of the ICH
in most cases and in all cases by 5 days post-ictus, with
tissue neutrophils evident up to 12 days. Notably, neu-
trophils were less numerous than macrophages through-
out the course of the post-ICH inflammatory response
in our cohort. Tissue macrophages were observed in
most of the cases (88%) from 2 days post-ICH, and
then in all subjects. We saw erythrocytes within the wall
of small vessels with arterial appearance, as well as
abnormal and swollen endothelial cells of small vessels
in most of our ICH cases from day 2. This suggests
active involvement of small vessels in the reaction fol-
lowing ICH and perhaps a role in trafficking or clear-
ance of hematoma-derived debris.
Lymphocytes, in particular T cells, are known to enter
brain tissue and have been reported to accumulate after
ischemic stroke.40 Subtypes of T cells (including NK cells)
that invade brain tissue are likely to contribute to local
inflammation and tissue damage. In sections labelled for
the pan-selective T-cell marker CD3, T cells were rou-
tinely seen in blood inside vessels which is expected as T
cells are a normal blood complement. We also observed
some T cells in Virchow-Robin spaces. The significance of
this is uncertain but the numbers of T cells were few and
not noticeably different between control and hemorrhage
cases. It could be that they represent a response to old
nonspecific minor insult (they were often associated with
a few hemosiderin-laden macrophages). None of the con-
trols showed parenchymal T cells. Out of 12 ICH cases
(1–3 days post-ICH) assessed only one case showed some
T cells. We also noted scanty T cells in two cases (days 7
and 8 post-ICH) and one case (12 days post-ICH). Our
data suggest that the main response we see after ICH is
mainly mediated by microglia. Furthermore, future stud-
ies may explore any involvement of T cells following
brain hemorrhage.
Secondary brain injury following ICH involves activa-
tion of inflammatory pathways.19,21 Microglia are the resi-
dent immune cells of the brain and are the first glial cells
to react to brain hemorrhage.21,22,41 There is very limited
information concerning the microglial response in terms
of magnitude, cell morphology and temporal course in
spontaneous human ICH. In human ICH brain tissue
labelled with the microglial marker Iba142–45 and we
observed increased Iba1 expression in the peri-ICH
region. Iba1 expression was increased as early as 1 day
post-ICH, in contrast to animal studies where activated
microglia become apparent at day 3 after experimental
ICH.19,46
We did not observe a pronounced influence of patient
age, when we compared Iba1-positive AF% in people
under 60 versus those over 60 years of age. We noted a
Figure 5. Representative images of morphological microglial changes over time. (A) Day 1 post-ICH. Reactive and amoeboid/phagocytic microglia
were observed within 2 mm of the hemorrhage (red arrow shows the hemorrhage site). Activated microglia were seen within 5 mm beyond the
initial 2 mm zone around the hemorrhage and in white matter tracts (green arrows), (a1) shows a higher magnification of activated microglia.
Ramified microglia were observed far from the bleed (black arrow) and (a2) shows a higher magnification of ramified microglia distant from the
bleed. Panel (A) Scale bar = 5mm. Panel a1 scale bar = 50 µm. Panel a2 scale bar = 50 µm. (B) Day 3 post-ICH. Mainly reactive and amoeboid/
phagocytic microglia cells and occasional fusion microglia were observed within 2–3 mm of the hemorrhage site. We observed clusters of reactive
and amoeboid microglia (black arrows) within 2–3 mm of the hemorrhage. Scale bar = 2.5mm. (b) Magnified picture of microglia clusters
described in B. Scale bar = 50 µm. (C) Day 5 post-ICH. Activated, transitional, reactive, amoeboid, and a few giant microglia were observed
within 2–3 mm of hemorrhage. We noted clusters of reactive/amoeboid microglia around medium-sized blood vessels (black arrow) and at higher
magnification in panel (c). Reactive and transitional microglia were seen in the other parts of tissue section. No ramified microglia was observed.
Red arrows represent hemorrhage areas. Panel (C) Scale bar = 5mm. Panel (c) scale bar = 50 µm. (D) Day 7 post-ICH. Reactive, amoeboid/
phagocytic, microglia that started fusing and giant microglia/macrophages were observed within 2–3 mm of the hemorrhage site (green arrow)
and higher magnification presented in panel (d). Reactive and transitional microglia were seen around the hemorrhage site. No ramified microglia
was observed. Red arrows represent hemorrhage areas. Panel (D) Scale bar = 5mm. Panel (d) scale bar = 50 µm. (E) Quantification of the cell
body cross-sectional area in the different microglial morphologies, **P < 0.01; ***P < 0.001. ICH, intracerebral hemorrhage.
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trend for extensive Iba1-positive AF% in lobar ICH than
in deep ICH cases. If this is confirmed it may reflect dif-
ferences in the brain location of the hemorrhage or in the
underlying vascular pathology.
Microglial activation is defined as the process by which
microglia cells change shape, molecular signature, and cel-
lular physiology.47 In brain tissue of human ICH, we have
observed various microglial morphological changes
including activated, reactive, amoeboid microglia, as pre-
viously reported following injuries.23,31,32,45,48–50 The mor-
phology of microglia after hemorrhage was defined more
than 20 years ago.31 We have modified this previous clas-
sification to include morphologies observed in our ICH
cohort. Microglia with ramified morphology, assumed to
be in a physiological state, are extremely motile cells51
and key regulators of neuronal and synapse function,
actively participating to the synaptic activity in the adult
brain.52 Morphological changes are likely to reflect the
changes in microglial function. Therefore, based on the
timescale and the morphological changes observed (num-
ber and size of processes, cell body surface), we hypothe-
size the following progression of microglial fate. First,
ramified microglia become activated following ICH, likely
due to the blood–brain barrier breakdown progressing
through a transitional stage before they become reactive,
then amoeboid, reflecting increased phagocytic activity to
clear the brain from highly toxic components such as
blood cells and dead cells.
We report bi- or tri-nucleated giant amoeboid micro-
glia in the peri-hematoma zone, from 5 days post-ICH,
which we believe is a novel finding (see Fig. 6). Multinu-
cleated giant cell microglia have been previously reported
in association with viral encephalitis and HIV,53–57 but
not to our knowledge in human ICH. We speculate that
these giant cells represent fusion of neighboring activated
microglia to attain a greater phagocytic capacity (as previ-
ously reported for multinucleated giant cells57). Alterna-
tively, they may reflect dysfunctional, dying microglia that
are overwhelmed by the inflammation and cytotoxic envi-
ronment adjacent to the hematoma. A third possibility is
that rapid proliferation of microglia in response to acute
ICH could generate abnormal, multinucleated cells.
A limitation of our study is that the Iba1 marker,
though commonly used to identify microglia in histologi-
cal studies, does not discriminate subtypes of microglia or
distinguish microglia from monocyte/macrophages. This
becomes a pertinent issue in a setting like ICH with
robust infiltration of peripheral leukocytes and we are
exploring other markers, to distinguish distinct subtypes
of microglia and macrophages, for a future report.
We conclude that neuroinflammatory changes occur
early after ICH in human patients, with tissue invasion by
leukocytes (neutrophils, macrophages) from day 1. Micro-
glia were significantly activated from day 1 post-ICH,
with a characteristic temporal course and changes in cell
morphology up to 12 days post-ictus. Bi- or tri-nucleated
giant microglia, possibly resulting from microglial fusion,
are a noticeable feature around the hematoma from day 5
and further study is required to understand the functional
role of these cells in ICH.
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Figure S1. Control case. T cells around a vessel in the
Virchow-Robin space. Immunohistochemistry for CD3,
209 magnification, scale bar = 100 µm.
Figure S2. Hemorrhage case at 3 days. Brain parenchymal
T cells. Immunohistochemistry for CD3, 809 magnifica-
tion, scale bar = 20 µm.
Figure S3. Hemorrhage case at 12 days. T cells in the
brain parenchyma and associated with vascularisation (or-
ganisation/repair) response. Immunohistochemistry for
CD3, 209 magnification, scale bar = 100 µm.
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